Description
An anthracycline with anticancer activity; interacts with topoisomerase II; inhibits the growth of human HeLa and C33A cervical, as well as T-24 bladder cancer cells (IC50s = 29, 52, and 36 ng/ml, respectively); inhibits the growth of human Huh7 and MHCC97H liver cancer cells (IC50s = 0.159 and 0.374 μM, respectively); inhibits the growth of mouse M5076 ovarian cancer cells in vitro (IC50 = 0.366 μM) and in vivo in a mouse allograft model at 2 mg/kg for four days
Formal name: (8S,10S)-10-[[3-amino-2,3,6-trideoxy-4-O-[(2R)-tetrahydro-2H-pyran-2-yl]-α-L-lyxo-hexopyranosyl]oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(2-hydroxyacetyl)-1-methoxy-5,12-naphthacenedione
Synonyms:
Molecular weight: 627.6
CAS: 72496-41-4
Purity: ≥95%
Formulation: A solid